Literature DB >> 29209802

[Doping for the brain].

Bernhard Iglseder1.   

Abstract

The enhancement of physical and cognitive abilities (i. e. concentration, vigilance, memory) has always been desirable for humans. The term pharmacological neuroenhancement refers to the use of legal or nonprescription psychoactive substances by healthy subjects with the intention of cognitive enhancement. To give the most prominent example, caffeine serves worldwide as a natural stimulant. Brain doping, however, specifies the use of illegal substances or prescription drugs beyond approval with the purpose of cognitive enhancement. Only amphetamines, methylphenidate and modafinil have significant effects on attentiveness, concentration and alertness, whereas other substances, such as anti-dementia drugs or anti-depressants failed to demonstrate cognitive enhancement in healthy subjects.

Entities:  

Keywords:  Brain doping; Cognition; Enhancement; Neuroenhancement; Psychotropic drugs

Mesh:

Substances:

Year:  2017        PMID: 29209802     DOI: 10.1007/s00391-017-1351-y

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  38 in total

Review 1.  Non-pharmacological Approaches to Cognitive Enhancement.

Authors:  Áine M Kelly
Journal:  Handb Exp Pharmacol       Date:  2015

Review 2.  Cocoa and chocolate in human health and disease.

Authors:  David L Katz; Kim Doughty; Ather Ali
Journal:  Antioxid Redox Signal       Date:  2011-06-13       Impact factor: 8.401

3.  Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil.

Authors:  William D S Killgore; Ellen T Kahn-Greene; Nancy L Grugle; Desiree B Killgore; Thomas J Balkin
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

4.  Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement.

Authors:  Miho Ota; Junko Matsuo; Ikki Ishida; Kotaro Hattori; Toshiya Teraishi; Hidekazu Tonouchi; Kinya Ashida; Takeshi Takahashi; Hiroshi Kunugi
Journal:  Psychopharmacology (Berl)       Date:  2016-08-27       Impact factor: 4.530

Review 5.  Ginkgo biloba for cognitive impairment and dementia.

Authors:  Jacqueline Birks; John Grimley Evans
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

6.  Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkers.

Authors:  Joshua H Balsters; Redmond G O'Connell; Mary P Martin; Alessandra Galli; Sarah M Cassidy; Sophia M Kilcullen; Sonja Delmonte; Sabina Brennan; Jim F Meaney; Andrew J Fagan; Arun L W Bokde; Neil Upton; Robert Lai; Marc Laruelle; Brian Lawlor; Ian H Robertson
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

7.  Spermidine protects against α-synuclein neurotoxicity.

Authors:  Sabrina Büttner; Filomena Broeskamp; Cornelia Sommer; Maria Markaki; Lukas Habernig; Ali Alavian-Ghavanini; Didac Carmona-Gutierrez; Tobias Eisenberg; Eva Michael; Guido Kroemer; Nektarios Tavernarakis; Stephan J Sigrist; Frank Madeo
Journal:  Cell Cycle       Date:  2014       Impact factor: 5.173

Review 8.  The Safety of Ingested Caffeine: A Comprehensive Review.

Authors:  Jennifer L Temple; Christophe Bernard; Steven E Lipshultz; Jason D Czachor; Joslyn A Westphal; Miriam A Mestre
Journal:  Front Psychiatry       Date:  2017-05-26       Impact factor: 4.157

9.  Spermidine-triggered autophagy ameliorates memory during aging.

Authors:  Stephan J Sigrist; Didac Carmona-Gutierrez; Varun K Gupta; Anuradha Bhukel; Sara Mertel; Tobias Eisenberg; Frank Madeo
Journal:  Autophagy       Date:  2013-11-15       Impact factor: 16.016

10.  Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia.

Authors:  Masayuki Hashiguchi; Yuriko Ohta; Mikiko Shimizu; Junya Maruyama; Mayumi Mochizuki
Journal:  J Pharm Health Care Sci       Date:  2015-04-10
View more
  2 in total

Review 1.  Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.

Authors:  Johanna Daubner; Muhammad Imran Arshaad; Christina Henseler; Jürgen Hescheler; Dan Ehninger; Karl Broich; Oliver Rawashdeh; Anna Papazoglou; Marco Weiergräber
Journal:  Neural Plast       Date:  2021-01-13       Impact factor: 3.599

2.  Neuroenhancement: State of the Art and Future Perspectives.

Authors:  Donatella Marazziti; Maria Teresa Avella; Tea Ivaldi; Stefania Palermo; Lucia Massa; Alessandra Della Vecchia; Lucia Basile; Federico Mucci
Journal:  Clin Neuropsychiatry       Date:  2021-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.